A Study of RoActemra/Actemra (Tocilizumab) in Patients With Active Systemic Juvenile Idiopathic Arthritis (JIA)

Clinical trial NCT00642460 · COMPLETED

Trial details

NCT number: NCT00642460
Sponsor: Hoffmann-La Roche
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Juvenile Idiopathic Arthritis

Start date: 2008-05-01
Primary completion: 2009-09-01
Enrollment: 112

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.